Impact of tDCS on Cerebral Autoregulation
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of the study is to investigate whether there is a polarity-specific influence of tDCS on cerebral vasomotor reactivity monitored by transcranial doppler sonography.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 18, 2012
CompletedFirst Posted
Study publicly available on registry
May 31, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedMarch 16, 2016
March 1, 2016
1.9 years
December 18, 2012
March 15, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Cerebral vasomotor reactivity assessed by transcranial Dopplersonography
comparing cerebral vasomotor reactivity at baseline and after anodal/cathodal/sham stimulation
on 3 days within 12 weeks
Study Arms (3)
Anodal tDCS
EXPERIMENTALanaodal transcranial direct current stimulation
Cathodal tDCS
ACTIVE COMPARATORcathodal transcranial direct current stimulation
Sham tDCS
SHAM COMPARATORno stimulation
Interventions
Eligibility Criteria
You may qualify if:
- severe cerebral Microangiopathy
- NOTCH3 carrier
- Migraine with aura (IHS Classification ICHD-II)
- Stenosis \>80%, ECST-Criteria
You may not qualify if:
- seizure disorder
- history of severe alcohol or drug abuse, psychiatric illness like severe depression, poor motivational capacity
- dementia
- (1+2) history of stroke in past 3 months (3) migraine prophylaxis (4) contralateral stenosis \>50%,
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, Charité Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agnes Flöel, Prof. MD
Charite University, Berlin, Germany
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. med. Agnes Floeel
Study Record Dates
First Submitted
December 18, 2012
First Posted
May 31, 2013
Study Start
April 1, 2012
Primary Completion
March 1, 2014
Study Completion
March 1, 2014
Last Updated
March 16, 2016
Record last verified: 2016-03